se of intravenous drugs in short urinary tract procedures for early recovery.
Phase 3
- Conditions
- Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
- Registration Number
- CTRI/2022/12/048343
- Lead Sponsor
- Sangey Doma Tamang
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of ASA physical status 1 and 2. Patients able to comprehend and willing to participate. Patients scheduled for elective transurethral procedures.
Exclusion Criteria
Patientâ??s refusal to participate. Patients with known contraindication or sensitivity to study drugs. Patients on concomitant analgesic, sedative medication, or chronic use of an α-agonist. Patients with chronic renal insufficiency, liver dysfunction, psychiatric or emotional disorders, respiratory disorders, sleep apnea, second or third degree heart block.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recovery time and return of full psychomotor function by achieving the Aldrete score to 10 points.Timepoint: 10 mins, 20 mins, 30 mins, 40 mins, 50 min, 60 mins, 70 mins, 80 mins, 90 mins
- Secondary Outcome Measures
Name Time Method Analgesic/sedative effect of Dexmedetomidine- Ketamine and Ketamine- Midazomlam combinations (Requirement of rescue medications) <br/ ><br>Timepoint: 10 mins, 20 mins, 30 mins, 40 mins, 50 mins, 60 mins, 70 mins, 80 mins, 90 mins